Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis

Cytotherapy

Volumn 11, Issue 4, 2009, Pages 392-402

  Uckan, D ^a   Kilic, E ^a   Sharafi, P ^a,b   Kazik, M ^a   Kaya, F A ^a,c   Erdemli, E ^d   Can, A ^d   Tezcaner, A ^b   Kocaefe, C ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

Adipocyte; Differentiation; Hematopoietic stem cell; Mesenchymal stromal cell; Microenvironment; Osteoclast; Osteopetrosis; Stem cell

Indexed keywords

ACYL COENZYME A DESATURASE; ADIPONECTIN; ADIPOPHILIN; CALCIUM; GLYCOGEN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOGENESIS; ALBERS SCHOENBERG DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL POPULATION; CELL STRUCTURE; CELL VACUOLE; CHILD; CHIMERA; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; MALIGNANT INFANTILE OSTEOPETROSIS; MESENCHYMAL STEM CELL; MINERALIZATION; PRIORITY JOURNAL; RIBOSOME;

EID: 68049141862     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802582083     Document Type: Article

References (36)

1. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 2004;351:2839-49.
2. Gerritsen EJ, Vossen JM, van Loo IH et al. Autosomal recessive osteopetrosis: Variability of findings at diagnosis and during the natural course. Pediatrics 1994;93:247-53.
3. Coccia PF, Krivit W, Cervenka J et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980;302:701-8.
4. Kapelushnik J, Shalev C, Yaniv I et al. Osteopetrosis: A single centre experience of stem cell transplantation and prenatal diagnosis. Bone Marrow Transplant 2001;27:129-32.
5. Teitelbaum SL, Tondravi MM, Ross FP. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J Leukoc Biol 1997;61:381-8.
6. Matsuzaki K, Udagawa N, Takahashi N et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998;246:199-204.
7. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42.
8. Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med 2003;52:1-7.
9. Frattini A, Orchard PJ, Sobacchi C et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000;25: 343-6.
10. Kornak U, Kasper D, Bosl MR et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001;104: 205-15.
11. Shah GN, Bonapace G, Hu PY et al. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): Novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat 2004;24:272.
12. Owen M, Friedenstein AJ. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 1988;136:42-60.
13. Gregory CA, Prockop DJ, Spees JL. Non-hematopoietic bone marrow stem cells: Molecular control of expansion and differentiation. Exp Cell Res 2005;306:330-5.
14. Gundle R, Stewart K, Screen J. Isolation and culture of human bone-derived cells. In: Beresford N, Owen M, editors. Marrow Stromal Cell Culture. Cambridge: Cambridge University Press, 1998:43-66.
15. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4.
16. Bianco P, Riminucci M, Gronthos S et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001;19:180-92.
17. Ishii M, Koike C, Igarashi A et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun 2005;332:297-303.
18. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
19. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
20. Dennis JE, Carbillet JP, Caplan AI et al. The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 2002;170: 73-82.
21. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
22. Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev 2005;19:29-38.
23. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-43.
24. Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-6.
25. Le Blanc K, Pittenger M. Mesenchymal stem cells: Progress toward promise. Cytotherapy 2005;7:36-45.
26. Lazarus HM, Koc ON, Devine SM et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-98.
27. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
28. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5: 309-13.
29. Dennis JE, Merriam A, Awadallah A et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999;14:700-9.
30. Ichinose S, Tagami M, Muneta T et al. Morphological examination during in vitro cartilage formation by human mesenchymal stem cells. Cell Tissue Res 2005;322:217-26.
31. Lajeunesse D, Busque L, Menard P et al. Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant. J Clin Invest 1996;98:1835-42.
32. Gimble J. Marrow stromal adipocytes. In: Beresford N, Owen M, editors. Marrow Stromal Cell Culture. Cambridge: Cambridge University Press, 1998, pp. 67-87.
33. Sottile V, Seuwen K, Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif Tissue Int 2004;75:329-37.
34. Rubin CT, Capilla E, Luu YK et al. Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals. Proc Natl Acad Sci USA 2007;104:17879-84.
35. Rieger K, Marinets O, Fietz T et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol 2005;33:605-11.
36. Tolar J, Nauta AJ, Osborn MJ et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007;25:371-9.